Literature DB >> 13209356

Iron therapy in pregnancy; a comparative study of various modes.

R W DEVOE, L E MOSES.   

Abstract

Study was made of groups of pregnant patients who were given various hematinic agents from the seventh month of gestation to term.Dilute hydrochloric acid given with meals in usual doses produced no appreciable increase in the hemoglobin concentration, erythrocyte count or packed cell volume. Iron therapy in the form of orally administered ferrous sulfate, or orally administered ferrous sulfatemolybdenum oxide, or as intravenously administered saccharated iron oxide had a beneficial effect on these three factors in the blood.

Entities:  

Keywords:  ANEMIA/in pregnancy; IRON/therapeutic use; PREGNANCY/complications

Mesh:

Substances:

Year:  1954        PMID: 13209356      PMCID: PMC1532327     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  5 in total

1.  Iron metabolism in anemias in pregnancy.

Authors:  H G HAMILTON; R S HIGGINS; W S ALSOP
Journal:  South Med J       Date:  1953-02       Impact factor: 0.954

2.  The hematologic response of the pregnant woman to intravenous saccharated iron oxide.

Authors:  D B NICHOLSON; N S ASSALI
Journal:  Surg Gynecol Obstet       Date:  1952-05

3.  Iron and the "physiological" anaemia of pregnancy.

Authors:  N BENSTEAD; G W THEOBALD
Journal:  Br Med J       Date:  1952-02-23

4.  Anemia in pregnancy.

Authors:  K E COX
Journal:  Postgrad Med       Date:  1952-03       Impact factor: 3.840

5.  The treatment of iron deficiency anemia of pregnancy with intravenous iron.

Authors:  F D KARTCHNER; E G HOLMSTROM
Journal:  Am J Obstet Gynecol       Date:  1950-12       Impact factor: 8.661

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.